Bardy Diagnostics Revenue and Competitors

Seattle, WA USA

Location

$35.5M

Total Funding

Estimated Revenue & Valuation

  • Bardy Diagnostics's estimated annual revenue is currently $54M per year.(i)
  • Bardy Diagnostics received $Undisclosed in venture funding in July 2018.
  • Bardy Diagnostics's estimated revenue per employee is $313,750
  • Bardy Diagnostics's total funding is $35.5M.

Employee Data

  • Bardy Diagnostics has 172 Employees.(i)
  • Bardy Diagnostics grew their employee count by 11% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$44.9M143-30%$211.3MN/A
#2
$54M17211%$35.5MN/A
#3
$5.3M210%N/AN/A
#4
$18.3M73N/AN/AN/A
#5
$7.8M31-16%N/AN/A
#6
$58M23113%N/AN/A
#7
$6M24-11%N/AN/A
#8
$8M3210%N/AN/A
#9
$198.5M7913%N/AN/A
#10
$6.3M5025%$27.5MN/A
Add Company

Bardy Diagnostics, Inc. (bardydx.com) has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. Bardy Dx was founded to address the long-standing complaint in cardiac arrhythmia monitoring that traditional monitors were large, bulky, uncomfortable, and typically recorded noisy QRS signals. Our goal: to completely redesign an arrhythmia monitor with optimal signal detection, comfort, and ease of use. CAM is the first P-wave centric ECG monitor - a single-patient use monitor that records continuously for up to 7 days. This focus on the P-wave is a major new tool for cardiologists and cardiac rhythm specialists for accurately diagnosing arrhythmias.

keywords:N/A

$35.5M

Total Funding

172

Number of Employees

$54M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bardy Diagnostics News

2022-04-17 - Holter ECG Market Size, Scope And Forecast | Nissha Medical ...

... Hill-Rom services iRhythm Technologies AliveCor Cardiac Insight Inc., VitalConnect, LifeSignals Bardy Diagnostics Nasiff Associates,...

2022-04-17 - The global remote patient monitoring market to grow at a CAGR of 12.5% during 2021-2027

Bardy Diagnostics • Cardiomo • Cardiologs • Dragerwerk AG • Hoffmann-La Roche • GE Healthcare • GrandCare • Masimo Corporation • Medopad

2021-01-19 - Health tech giant Hillrom to acquire Seattle startup Bardy Diagnostics for $375M

Dr. Gust Bardy, founder of Bardy Diagnostics. (Bardy Photo) Hillrom, a publicly-traded medical device and digital health company based in Chicago, will pay $375 million to acquire Seattle startup Bardy Diagnostics. Founded in 2013, Bardy set out to change the way medical professionals monitor ...

2019-09-08 - FDA clears 14-Day version of ambulatory cardiac patch ...

The clearance was received by Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data ...

2019-09-07 - Bardy Diagnostics™ Receives FDA 510(k) Clearance for 14 ...

SEATTLE, Sept. 6, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc. Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.4M1723%N/A
#2
$38.2M1728%N/A
#3
$27.6M1734%N/A
#4
$30.4M1736%N/A
#5
$42.1M17431%N/A

Bardy Diagnostics Funding

DateAmountRoundLead InvestorsReference
2017-01-06$UndisclosedUndisclosedMultipleArticle
2018-07-19$UndisclosedUndisclosedSV Health InvestorsArticle